Ignite Creation Date:
2024-05-05 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00088673
Status:
UNKNOWN
Last Update Posted:
2007-02-28
First Post:
2004-07-30
Brief Title:
Evaluation of 3APS in Patients With Mild to Moderate Alzheimers Disease
Sponsor:
Bellus Health Inc - a GSK company
Organization:
Bellus Health Inc - a GSK company
Study Overview
Official Title:
A Phase III Study of the Efficacy and Safety of 3APS in Patients With Mild to Moderate Alzheimers Disease
Status:
UNKNOWN
Status Verified Date:
2007-02
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this Phase III study is to evaluate the efficacy and safety of 3APS compared to placebo inactive substance pill in patients with mild to moderate Alzheimers disease
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None